European Journal of Epidemiology

, Volume 16, Issue 1, pp 13–17 | Cite as

Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan

  • Nain-Feng Chu
  • Dan-Jiang Wang
  • Saou-Hsing Liou
  • Shyh-Ming Shieh


Hyperuricemia is associated with cardiovascular disease risk factors such as obesity, impaired glucose tolerance, hypertension, and hyperlipidemia. However, this relationship between serum uric acid (SUA) concentrations and cardiovascular disease (CVD) is a controversial one, especially among males. The purpose of this study is to evaluate the association between SUA concentrations and other CVD risk factors among adult males in Taiwan. After multi-stage sampling procedures, we randomly selected 1743 Taiwanese males with a mean age of 35 years (from 22 to 54) in this study. Anthropometric, blood pressure and biochemical variables, including serum uric acid, glucose, total cholesterol and triglyceride concentrations, were measured. Among the study population, the mean SUA concentration was 6.5 ± 1.5 mg/dl. There were 290 (16.6%) subjects with SUA concentrations ≥ 8.0 mg/dl (defined as hyperuricemia). Compared to normouricemic subjects, hyperuricemic subjects had significantly greater age-adjusted body weight (75.3 vs. 69.2 kg, p < 0.001), body mass index (BMI, 25.5 vs. 23.6 kg/m2, p < 0.001), higher blood pressure (BP, 120.2 vs. 115.2 mmHg for systolic BP and 78.5 vs. 75.3 mmHg for diastolic BP, both p < 0.001) and blood lipid concentrations (193.8 vs. 182.1 mg/dl for total cholesterol and 123.7 vs. 94.4 mg/dl for triglycerides, both p < 0.001). SUA concentration was positively correlated with body weight, BMI, BP and serum lipid concentrations (all p < 0.001). In multivariate regression analyses, after adjusting for potential confounders, SUA concentration was significantly positively associated with diastolic BP, serum total cholesterol and triglyceride concentrations. An increase of 1 mg/dl of SUA was associated with a 2.1 mg/dl elevation in serum total cholesterol (p < 0.001) and a 5.4 mg/dl increase in triglyceride (p < 0.001). From this study, we found that hyperuricemia in subjects is associated with being overweight, and having high blood pressure and hyperlipidemia. There is a significantly positive association between SUA concentration and other CVD risk factors among adult males in Taiwan.

Cardiovascular disease Hyperuricemia Risk factors Taiwanese males 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Department of Health, The Executive Yuan, ROC. Public Health in Taiwan Area, Republic of China, 1995.Google Scholar
  2. 2.
    Department of Health, The Executive Yuan, ROC. The National Nutritional Guide Book (II), 1991.Google Scholar
  3. 3.
    Levine W, Dyer AR, Shekelle RB, Schoenberger JAB, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: Findings of the Chicago heart association detection project in industry. J Clin Epidemiol 1989; 42: 257–267.PubMedGoogle Scholar
  4. 4.
    Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study. Am J Epidemiol 1995; 141: 637–644.PubMedGoogle Scholar
  5. 5.
    Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and cardiovascular disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome. Am J Epidemiol 1995; 142: 288–294.PubMedGoogle Scholar
  6. 6.
    Kotake H, Sawada Y, Hoshio A, Shirota K, Tomokuni A, Doi T, Hisatome I, Mashiba H. Relation between serum uric acid and angiographically defined coronary artery disease in postmenopausal women. J Med 1992; 23: 409–415.PubMedGoogle Scholar
  7. 7.
    Fessel WJ. High uric acid as an indicator of cardiovascular disease. Independent from obesity. Am J Med 1980; 68: 401–404.PubMedGoogle Scholar
  8. 8.
    Persky VW, Dyer AR, Idris-Soven E, Stamler J, Shekelle RB, Schoenberger JAB, Berkson DM, Lindberg HA. Uric acid: a risk factor for cardiovascular disease? Circulation 1979; 59: 969–977.PubMedGoogle Scholar
  9. 9.
    Jacobs D. Hyperuricemia as a risk factor in cardiovascular disease. Adv Exp Med Biol 1977; 76B: 231–237.PubMedGoogle Scholar
  10. 10.
    Brand FN, McGee DL, Kannel WB, Stokes III J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121: 11–18.PubMedGoogle Scholar
  11. 11.
    Iribarren C, Sharp DS, Curb JD, Yano K. High uric acid: A metabolic marker of coronary heart disease among alcohol abstainers? J Clin Epidemiol 1996; 49: 673–678.PubMedGoogle Scholar
  12. 12.
    Hisatome I, Saitoh M, Ogino K, Miyamoto J, Hoshio A, Ishiko R, Hasegawa J, Kotake H, Mashiba H. Differences in urate metabolism between normouricemia and hyperuricemia in cardiovascular disease in men. J Med 1990; 20: 363–370.Google Scholar
  13. 13.
    Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997; 78: 147–153.PubMedGoogle Scholar
  14. 14.
    Liang JK. A clinical study of hyperuricemia men. N Z Med J 1975; 82: 408–410.PubMedGoogle Scholar
  15. 15.
    Mustard JF, Murphy EA, Orryzlo MA, et al. Blood coagulation and platelet economy in subjects with primary gout. Can Med Assoc J 1963; 89: 1207–1211.PubMedGoogle Scholar
  16. 16.
    Newland H. Hyperuricemia in coronary, cerebral, and peripheral arterial disease: an explanation. Med Hypotheses 1975; 1: 152–155.PubMedGoogle Scholar
  17. 17.
    Frolich ED. Uric acid: A risk factor for cardiovascular disease. JAMA 1993; 270: 378–379.PubMedGoogle Scholar
  18. 18.
    Messerli FH, Frolich ED, Dreslinski GR, et al. Serum uric acid in essential hypertension: An indicator of renal vascular involvement. Ann Intern Med 1980; 93: 817–821.PubMedGoogle Scholar
  19. 19.
    Tweeddale MG, Fodor JG. Elevated serum uric acid. A cardiovascular risk factor? Nephron 1979; 23, Suppl 1: 3–6.PubMedGoogle Scholar
  20. 20.
    Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD. Clustering of cardiovascular disease risk factors. Prev Med 1980; 9: 525–533.PubMedGoogle Scholar
  21. 21.
    Kannel WB, Wilson PWF. An update on coronary risk factors. Med Clin North Am 1995; 79: 951–971.PubMedGoogle Scholar
  22. 22.
    Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L, Muggeo M. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes 1996; 20: 975–980.Google Scholar
  23. 23.
    Kadish AH, Litle RL, Sternberg JC. A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968; 14: 116–131.Google Scholar
  24. 24.
    Leon LP, Chu DK, Stasiw RP, et al. New, more specific methods for the SMA 12/60 multichannel biochemical analyzer. In: Advances in automated analysis. (Proceedings of the Technicon International Congress, 1976). Vol 1. Tarrytown, NY: Mediad, Inc., 1977: 152–156.Google Scholar
  25. 25.
    Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19: 1350–1356.PubMedGoogle Scholar
  26. 26.
    Stavropoulos WS, Crouch RD. A new colorimetric procedure for the determination of serum triglyceride. Clin Chem 1974; 20: 857.Google Scholar
  27. 27.
    Okada M, Ueda K, Omae T, Takeshita M, Hirota Y. The relationship of serum uric acid to hypertension and ischemic heart disease in Hisayama population, Japan. J Chron Dis 1982; 35: 173–178.PubMedGoogle Scholar
  28. 28.
    Reunanen A, Takkunen H, Knekt P, Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand 1982; 668 Suppl: 49–59.Google Scholar
  29. 29.
    Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: The ARIC Study. Ann Epidemiol 1996; 6: 331–340.PubMedGoogle Scholar
  30. 30.
    Yu T, Talbott JH. Changing trends of mortality in gout. Seminars Arth Rheum 1980; 10: 1–9.Google Scholar
  31. 31.
    Cook DG, Sharper AG, Thelle DS, Whitehead TP. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986; 1001–1006.Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Nain-Feng Chu
    • 1
    • 2
  • Dan-Jiang Wang
    • 2
  • Saou-Hsing Liou
    • 1
  • Shyh-Ming Shieh
    • 2
  1. 1.Department of Public Health, Tri-Service General HospitalNational Defense Medical CenterTaipeiTaiwan, ROC
  2. 2.Department of Internal Medicine, Tri-Service General HospitalNational Defense Medical CenterTaipeiTaiwan, ROC

Personalised recommendations